Immunokinetics in Severe Pneumonia Reveals Bacterial-Influenza Coinfection Mechanisms

According to recent research from Japan, coinfections of bacteria and influenza are a major cause of excessive mortality during influenza epidemics. In a study published in the European Respiratory Journal, scientists found that mice infected with influenza virus and then with Streptococcus pneumoniae developed severe bronchopneumonia with massive hemorrhage, leading to death within 2 days. The researchers also identified immune mediators, including cytokines and chemokines, as playing a crucial role in the pathology of coinfection.

Key Takeaways:

• Coinfections of bacteria and influenza virus are a major cause of excessive mortality during influenza epidemics.
• Mice inoculated with influenza virus followed by Streptococcus pneumoniae developed severe bronchopneumonia with massive hemorrhage, leading to death within 2 days.
• Short-term survival correlated with pathological changes in the lungs of infected mice.
• Intrapulmonary levels of inflammatory cytokines/chemokines, type-1 T-helper cell cytokines, and Toll-like receptors were increased in coinfected mice.
• Immune mediators, including cytokines and chemokines, through Toll-like receptors/mitogen-activated protein kinase pathways, play important roles in the pathology of coinfection.
• The study suggests that understanding the synergy between influenza virus and bacteria is crucial for developing effective treatments.
• The research was conducted by M. Seki and colleagues from Nagasaki University, School of Medicine.

Statistics:

• 2 days: The time it took for mice to develop severe bronchopneumonia and die after inoculation with Streptococcus pneumoniae.
• 24(1):143-149: The volume and page numbers of the European Respiratory Journal issue where the study was published.
• 2 days: The time period during which pathological changes in the lungs and massive hemorrhage occurred in coinfected mice.

Sources:

• Seki, M. et al. (2004). Immunokinetics in severe pneumonia due to influenza virus and bacteria coinfection in mice. Eur Resp J, 24(1), 143-149.
• European Respiratory Society Journals Ltd. (Publisher)
• Hematology Week (2004, Copyright) via NewsRx.com & NewsRx.net.